• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用于微球制造工艺的非卤代有机溶剂的鉴定

Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.

作者信息

Shim Hyunjin, Sah Hongkee

机构信息

College of Pharmacy, Ewha Womans University, 52 Ewhayeodaegil, Seodaemun-gu, Seoul 03760, Korea.

出版信息

Pharmaceutics. 2020 May 6;12(5):425. doi: 10.3390/pharmaceutics12050425.

DOI:10.3390/pharmaceutics12050425
PMID:32384751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7285046/
Abstract

As a non-halogenated dispersed solvent, ethyl acetate has been most commonly used for the manufacturing of poly-d,l-lactide--glycolide (PLGA) microspheres. However, ethyl acetate-based microencapsulation processes face several limitations. This study was aimed at proposing ethyl formate as an alternative. Evaluated in this study was the solvent qualification of ethyl formate and ethyl acetate for microencapsulation of a hydrophobic drug into PLGA microspheres. An oil-in-water emulsion solvent extraction technique was developed to load progesterone into PLGA microspheres. Briefly, right after emulsion droplets were temporarily stabilized, they were subject to primary solvent extraction. Appearing semisolid, embryonic microspheres were completely hardened through subsequent secondary solvent extraction. Changes in process parameters of the preparative technique made it possible to manipulate the properties of emulsion droplets, progesterone behavior, and microsphere quality. Despite the two solvents showing comparable Hansen solubility parameter distances toward PLGA, ethyl formate surpassed ethyl acetate in relation to volatility and water miscibility. These features served as advantages in the microsphere manufacturing process, helping produce PLGA microspheres with better quality in terms of drug crystallization, drug encapsulation efficiency, microsphere size homogeneity, and residual solvent content. The present ethyl formate-based preparative technique could be an attractive method of choice for the production of drug-loaded PLGA microspheres.

摘要

作为一种非卤代分散溶剂,乙酸乙酯最常用于聚(d,l-丙交酯-乙交酯)(PLGA)微球的制造。然而,基于乙酸乙酯的微囊化工艺面临若干限制。本研究旨在提出用甲酸乙酯作为替代物。本研究评估了甲酸乙酯和乙酸乙酯用于将疏水性药物微囊化到PLGA微球中的溶剂适用性。开发了一种水包油乳液溶剂萃取技术,将黄体酮载入PLGA微球。简而言之,乳液滴暂时稳定后,立即进行一次溶剂萃取。呈半固体状的胚胎微球通过随后的二次溶剂萃取完全硬化。制备技术工艺参数的改变使得调控乳液滴的性质、黄体酮行为和微球质量成为可能。尽管两种溶剂对PLGA的汉森溶解度参数距离相当,但甲酸乙酯在挥发性和与水的混溶性方面超过了乙酸乙酯。这些特性在微球制造过程中具有优势,有助于生产出在药物结晶、药物包封效率、微球尺寸均匀性和残留溶剂含量方面质量更好的PLGA微球。基于甲酸乙酯的现行制备技术可能是生产载药PLGA微球的一种有吸引力的选择方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/0d828f1cf44d/pharmaceutics-12-00425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/5156a42015d8/pharmaceutics-12-00425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/ea99f32678d9/pharmaceutics-12-00425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/1a6db9d8bf4a/pharmaceutics-12-00425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/aed10843c63a/pharmaceutics-12-00425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/94969f43541e/pharmaceutics-12-00425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/4a7edfb75ac9/pharmaceutics-12-00425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/0d828f1cf44d/pharmaceutics-12-00425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/5156a42015d8/pharmaceutics-12-00425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/ea99f32678d9/pharmaceutics-12-00425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/1a6db9d8bf4a/pharmaceutics-12-00425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/aed10843c63a/pharmaceutics-12-00425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/94969f43541e/pharmaceutics-12-00425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/4a7edfb75ac9/pharmaceutics-12-00425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/046d/7285046/0d828f1cf44d/pharmaceutics-12-00425-g007.jpg

相似文献

1
Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.应用于微球制造工艺的非卤代有机溶剂的鉴定
Pharmaceutics. 2020 May 6;12(5):425. doi: 10.3390/pharmaceutics12050425.
2
Solvent hydrolysis rate determines critical quality attributes of PLGA microspheres prepared using non-volatile green solvent.溶剂水解速率决定了使用非挥发性绿色溶剂制备的 PLGA 微球的关键质量属性。
J Biomater Sci Polym Ed. 2018 Jan;29(1):35-56. doi: 10.1080/09205063.2017.1398993. Epub 2017 Nov 6.
3
Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres.甲酸乙酯——用于制备聚乳酸-羟基乙酸共聚物(PLGA)微球的替代分散溶剂。
Int J Pharm. 2000 Feb 15;195(1-2):103-13. doi: 10.1016/s0378-5173(99)00379-8.
4
Investigation on structural integrity of PLGA during ammonolysis-based microencapsulation process.基于氨解的微囊化过程中 PLGA 的结构完整性研究。
Int J Pharm. 2011 Oct 31;419(1-2):60-70. doi: 10.1016/j.ijpharm.2011.07.022. Epub 2011 Aug 4.
5
Applicability of non-halogenated methyl propionate to microencapsulation.
J Microencapsul. 2014;31(4):323-32. doi: 10.3109/02652048.2013.843729. Epub 2013 Nov 1.
6
Another paradigm in solvent extraction-based microencapsulation technologies.基于溶剂萃取的微胶囊化技术的另一种范例。
Biomacromolecules. 2010 Mar 8;11(3):776-86. doi: 10.1021/bm9013952.
7
Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.基于氨解的微胶囊化技术,使用异丙基甲酸酯作为分散溶剂。
Int J Pharm. 2009 Dec 1;382(1-2):130-8. doi: 10.1016/j.ijpharm.2009.08.020. Epub 2009 Aug 26.
8
Merits of sponge-like PLGA microspheres as long-acting injectables of hydrophobic drug.作为疏水性药物的长效注射剂,海绵状 PLGA 微球的优点。
J Biomater Sci Polym Ed. 2019 Dec;30(18):1725-1743. doi: 10.1080/09205063.2019.1659712. Epub 2019 Sep 10.
9
Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.基于乙酸乙酯的微囊化过程中影响蛋白质包封到聚乳酸-羟基乙酸共聚物(PLGA)微球中的配方和工艺参数。
J Microencapsul. 2005 Feb;22(1):1-12. doi: 10.1080/02652040400026269.
10
Nonhalogenated solvent-based solvent evaporation process useful in preparation of PLGA microspheres.非卤化溶剂的溶剂蒸发过程可用于制备 PLGA 微球。
J Microencapsul. 2011;28(6):490-8. doi: 10.3109/02652048.2011.586066.

引用本文的文献

1
Clinical research progress of callisperes of drug-loaded microsphere arterial chemoembolisation in the treatment of solid tumors.载药微球动脉化疗栓塞术治疗实体瘤的临床研究进展
Discov Oncol. 2024 May 13;15(1):161. doi: 10.1007/s12672-024-01030-z.
2
PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery.PLGA/PLA 基长效注射储库微球的临床应用:蛋白/肽给药的生产和特性概述。
Int J Mol Sci. 2021 Aug 18;22(16):8884. doi: 10.3390/ijms22168884.
3
studies and preclinical evaluation of benznidazole microparticles in the acute murine model.

本文引用的文献

1
Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats.聚(丙交酯-乙交酯)微球的制备及大鼠体内BDMC-PLGA-MS的药代动力学和组织分布评价
Asian J Pharm Sci. 2018 Jan;13(1):82-90. doi: 10.1016/j.ajps.2017.09.002. Epub 2017 Oct 10.
2
Design and In Vivo Pharmacokinetic Evaluation of Triamcinolone Acetonide Microcrystals-Loaded PLGA Microsphere for Increased Drug Retention in Knees after Intra-Articular Injection.关节腔内注射用曲安奈德微晶负载聚乳酸-羟基乙酸共聚物微球的设计及体内药代动力学评价:用于提高膝关节内药物滞留率
Pharmaceutics. 2019 Aug 19;11(8):419. doi: 10.3390/pharmaceutics11080419.
3
贝诺喹微球在急性鼠模型中的研究和临床前评价。
Parasitology. 2021 Apr;148(5):566-575. doi: 10.1017/S0031182020002310. Epub 2020 Dec 10.
4
Assessment of Residual Solvent and Drug in PLGA Microspheres by Derivative Thermogravimetry.采用导数热重分析法评估聚乳酸-羟基乙酸共聚物微球中的残留溶剂和药物
Pharmaceutics. 2020 Jul 4;12(7):626. doi: 10.3390/pharmaceutics12070626.
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation.
可注射、长效 PLGA 制剂:分析 PLGA 和了解微球形成。
J Control Release. 2019 Jun 28;304:125-134. doi: 10.1016/j.jconrel.2019.05.003. Epub 2019 May 6.
4
Encapsulation of nor-β-lapachone into poly(d,l)-lactide--glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines.将去甲-β-拉帕醌包裹于聚(d,l)-丙交酯-乙交酯(PLGA)微囊中:全面表征、计算细节及对人癌细胞系的细胞毒性活性
Medchemcomm. 2017 Sep 7;8(10):1993-2002. doi: 10.1039/c7md00196g. eCollection 2017 Oct 1.
5
Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.微球中的药物分布增强了其在哥廷根小型猪中的抗炎特性。
Mol Pharm. 2015 Sep 8;12(9):3332-8. doi: 10.1021/acs.molpharmaceut.5b00326. Epub 2015 Aug 10.
6
Stability Evaluation of Ivermectin-Loaded Biodegradable Microspheres.伊维菌素负载型可生物降解微球的稳定性评估
AAPS PharmSciTech. 2015 Oct;16(5):1129-39. doi: 10.1208/s12249-015-0305-1. Epub 2015 Feb 21.
7
Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.预测聚合物基质中药物释放的简单测量方法——溶解度参数和特性粘度。
Eur J Pharm Biopharm. 2015 May;92:1-7. doi: 10.1016/j.ejpb.2015.02.001. Epub 2015 Feb 7.
8
Influence of different formulations and process parameters during the preparation of drug-loaded PLGA microspheres evaluated by multivariate data analysis.通过多变量数据分析评估载药PLGA微球制备过程中不同配方和工艺参数的影响。
Acta Pharm. 2014 Dec;64(4):403-17. doi: 10.2478/acph-2014-0032.
9
Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres.萘普生在有机溶剂中的溶液热力学性质与其从 PLGA 微球中释放的关系。
J Microencapsul. 2013;30(3):218-24. doi: 10.3109/02652048.2012.717114. Epub 2013 Feb 1.
10
Application of Hansen solubility parameters for understanding and prediction of drug distribution in microspheres.利用 Hansen 溶解度参数理解和预测药物在微球中的分布。
Int J Pharm. 2011 Sep 15;416(1):202-9. doi: 10.1016/j.ijpharm.2011.06.047. Epub 2011 Jul 1.